We have shown here that the presence of FAP-a in stromal fibroblasts and GOLPH3 in carcinoma cells are reliable biomarker of DCIS recurrence and progression into invasive breast cancer. The gene discussed is FAP; the disease is ductal breast carcinoma in situ.